POLL: Are you planning to attend the American Academy of Ophthalmology Meeting?

Poll
Conference|AAO

A poll for retina specialists regarding their attendance at the 2021 American Academy of Ophthalmology Meeting in New Orleans, Louisiana. This poll is now closed.

POLL: Are you planning to attend the American Academy of Ophthalmology Meeting?

Do you plan to attend the 2021 AAO Meeting?

Yes, I will be there in person
Yes, I will attend virtually
No, I am unable to attend

Related Content: Ophthalmology | Conference Coverage | News

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Subscribe Now!
Recent Videos
Carl Danzig, MD, director of vitreo-retinal services at the Rand Eye Institute in Deerfield Beach, Florida, shared an update on his research in OCS-01 drops for diabetic macular edema during ARVO
Jennifer Lim, MD, FARVO, FASRS, from the University of Illinois at Chicago, discussed her ARVO presentation on sickle cell retinopathy. She highlighted improvements in retinal surgery techniques and instrumentation.
At ARVO 2025, Christine Kay, MD, shares interim results from the PRISM trial population extension cohort
ARVO 2025: Rishi Singh, MD, discusses real-world clinical outcomes in patients with DME
Abby Markward and Hattie Hayes discuss the ASCRS Annual Meeting, the ASOA Annual Meeting, and the Retina Day event.
WIO 2024: An educator's perspective on shattering glass ceilings in ophthalmology
Hannah Chiu, MD, FRCSC, highlights some of the early benefits of an AI-operated telephone call system for postoperative patient care at WIO 2024
Related Content
Positive preclinical data on melanocortin agonists for retinopathy

Positive preclinical data on melanocortin agonists for retinopathy

Kassi Filkins
May 14th 2025
Article
Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

Alex Delaney-Gesing ;David Hutton
December 1st 2020
Podcast
AAVantgarde Bio presents positive data for retinitis pigmentosa and Stargardt disease therapies

AAVantgarde Bio presents positive data for retinitis pigmentosa and Stargardt disease therapies

Hattie Hayes
May 13th 2025
Article
What to expect from virtual AAO 2020

What to expect from virtual AAO 2020

Alex Delaney-Gesing
November 5th 2020
Podcast
Boehringer Ingelheim launches two Phase 2 clinical trials for its geographic atrophy treatment candidates

Boehringer Ingelheim launches two Phase 2 clinical trials for its geographic atrophy treatment candidates

Emily Kaiser Maharjan
May 12th 2025
Article
Q&A: Katherine Talcott, MD, on exploring a potential connection between autoimmune diseases and AMD

Q&A: Katherine Talcott, MD, on exploring a potential connection between autoimmune diseases and AMD

Sydney M Crago
May 11th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.